Skip to main content
. 2021 May 17;11:10387. doi: 10.1038/s41598-021-89991-x

Table 4.

Association between serum iron, ferritin, TFR (per SD increment) and the presence of NAFLD or AHF.

Cases/participants Model 1
OR (95% CI)
P Model 2
OR (95% CI)
P Model 3
OR (95% CI)
P
NAFLD
Males
Serum iron 8808/18,031 0.86 (0.82–0.89)  < 0.001 0.87 (0.83–0.91)  < 0.001 0.87 (0.83–0.91)  < 0.001
Ferritin 2456/5044 1.46 (1.32–1.62)  < 0.001 1.45 (1.30–1.62)  < 0.001 1.44 (1.30–1.61)  < 0.001
TFR 926/1675 1.22 (0.98–1.52) 0.08 1.23 (0.97–1.56) 0.08 1.22 (0.95–1.56) 0.12
Females
Serum iron 7464/18,989 0.73 (0.69–0.76)  < 0.001 0.75 (0.72–0.78)  < 0.001 0.75 (0.71–0.78)  < 0.001
Ferritin 3908/11,006 1.34 (1.27–1.43)  < 0.001 1.37 (1.29–1.45)  < 0.001 1.36 (1.28–1.45)  < 0.001
TFR 2632/7419 1.38 (1.29–1.48)  < 0.001 1.37 (1.28–1.47)  < 0.001 1.40 (1.30–1.50)  < 0.001
AHF
Males
Serum iron 646/17,935 0.86 (0.77–0.95) 0.005 0.89 (0.79–0.99) 0.036 0.89 (0.79–1.00) 0.055
Ferritin 162/5031 1.00 (0.74–1.37) 0.99 1.00 (0.74–1.37) 0.99 0.97 (0.71–1.32) 0.84
TFR 110/1665 2.22 (1.46–3.40)  < 0.001 2.16 (1.46–3.21)  < 0.001 2.13 (1.39–3.24)  < 0.001
Females
Serum iron 640/18,913 0.82 (0.74–0.92)  < 0.001 0.87 (0.78–0.98) 0.023 0.87 (0.77–0.98) 0.025
Ferritin 196/10,963 1.05 (0.79–1.39) 0.75 1.04 (0.78–1.38) 0.81 1.01 (0.75–1.36) 0.94
TFR 134/7382 1.72 (1.39–2.12)  < 0.001 1.68 (1.35–2.09)  < 0.001 1.73 (1.37–2.17)  < 0.001

Model 1: age (years), race (Mexican American, other Hispanic, non-Hispanic white, non-Hispanic black, other race), marital status (married or cohabitation, widowed or separated, never married), education level (less than 12th grade, high school or equivalent, college graduate or above), family poverty income ratio; Model 2: model 1 + smoking status (never, ever, current), alcohol intake (drinkers/week), leisure activity (MET-min/day), total energy intake (kcal/day), healthy eating index-2015; Model 3: model 2 + lead (μg/dL), cadmium (nmol/L).

AHF advanced hepatic fibrosis, MET metabolic equivalent, NAFLD non-alcohol fatty liver disease, SD standard deviation, TFR transferrin receptor.